Relationship between pathologic types, CD4 cells, and survival in marrow-positive and marrow-negative cases of systemic acquired immunodeficiency syndrome–related lymphoma
| . | Small noncleaved . | Immunoblastic . | Diffuse large cell . | |||
|---|---|---|---|---|---|---|
| Median . | P . | Median . | P . | Median . | P . | |
| BM+ | ||||||
| CD4, cells/μL (range) | 161 (12-819) | .16 | 100 (13-710) | .024 | 60 (1-579) | .61 |
| Survival, months | 5.36 | .13 | 5.95 | .45 | Not reached | .08 |
| BM− | ||||||
| CD4+, cells/μL (range) | 111 (0-920) | .16 | 52 (0-978) | .024 | 42 (12-503) | .61 |
| Survival, months | 6.05 | .13 | 7.60 | .45 | 7.63 | .08 |
| . | Small noncleaved . | Immunoblastic . | Diffuse large cell . | |||
|---|---|---|---|---|---|---|
| Median . | P . | Median . | P . | Median . | P . | |
| BM+ | ||||||
| CD4, cells/μL (range) | 161 (12-819) | .16 | 100 (13-710) | .024 | 60 (1-579) | .61 |
| Survival, months | 5.36 | .13 | 5.95 | .45 | Not reached | .08 |
| BM− | ||||||
| CD4+, cells/μL (range) | 111 (0-920) | .16 | 52 (0-978) | .024 | 42 (12-503) | .61 |
| Survival, months | 6.05 | .13 | 7.60 | .45 | 7.63 | .08 |
BM indicates bone marrow.